Latest From Biotech Now

Empowering You to Make a Difference in Health Care Policy

CMM

Access to medicines. Healthcare reform. Innovation. These issues are critical to the health of Americans — and the Campaign for Modern Medicines is working on them every day. The Campaign for Modern Medicines is a coalition of non-profit organizations, businesses, and individuals from across the country who believe that a vibrant community of empowered advocates can make a real impact on the policy decisions that will improve our health. With the support of our partners, Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , ,

What BIO2012 Meant to Boston and the Netherlands

The 2012 BIO International Convention will be held June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA

We came across this recent post in Boston.com about the BIO International Convention and BIO Business Forum. It’s not just a recap of the event, but it’s a specific piece on one company’s goals, connecting Boston with the Netherlands. As you know, the BIO One-on-One Partnering System is open and accessible to attendees well after the conference shuts down and everyone goes home. This allows you to do your follow-up: go through your Inbox, research Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Novartis at India Supreme Court: Evergreening Myths and Patent Reality

Pine

Novartis will go before India’s Supreme Court on September 11, 2012 challenging the refusal by the Indian Patent Office to grant a patent on its cancer drug Glivec.  The Indian Patent Office rejected Novartis’ application under a provision in Indian law which is aimed at guarding against so called “patent evergreening.” BIO has written two posts deconstructing the myth of patent evergreening. 1.  Patent “Ever-Greening”: Novartis Confronts Patent Myth in India 2.  Patent Evergreening in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Sequestration Will Be Devastating to the Cure Enterprise

Margaret Anderson

For months, the defense industry has taken the Hill and media outlets by storm detailing the potentially catastrophic impact “sequestration” will have on national security, defense jobs, and our economy. The “S” word stands for automatic spending cuts that will take into effect if Congress does not reach a budget agreement to reduce the deficit by the end of the year. Members of Congress have expressed concern over the potential cuts to defense programs, and even Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

AMP v. Myriad: BIO Statement on Federal Circuit (Re)Decision

courtroom

BIO released the following statement on the Federal Circuit’s decision in the AMP v. Myriad case on remand from the Supreme Court to reconsider in light of Mayo v. Prometheus. “Today’s decision by the U.S. Court of Appeals for the Federal Circuit confirms long-standing law under which valuable DNA preparations, bacterial enzymes, plant-derived antibiotics and other industrially and medically useful substances can be considered for patenting. Such patents have long provided critical incentives for expensive Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,